Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies

BACKGROUND: Polycystic ovary syndrome (PCOS) is the most common endocrinopathy among reproductive age women. Although its cardinal manifestations include hyperandrogenism, oligo/anovulation, and/or polycystic ovarian morphology, PCOS women often display also notable metabolic comorbidities. An array...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanchez-Garrido, Miguel A., Tena-Sempere, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115104/
https://www.ncbi.nlm.nih.gov/pubmed/32244180
http://dx.doi.org/10.1016/j.molmet.2020.01.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115104/
https://www.ncbi.nlm.nih.gov/pubmed/32244180
http://dx.doi.org/10.1016/j.molmet.2020.01.001

Ejemplares similares